HALEON PLC ADR (HLN)
Haleon plc ADR is a depositary receipt representing common stock of Haleon plc and is listed on the NYSE under the ticker HLN. Haleon and its subsidiaries develop, manufacture, and sell consumer healthcare products across North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific region. Its portfolio includes oral health products such as toothpaste, mouthwash, and denture care items, along with vitamins, minerals, and supplements. The company also sells over-the-counter products for respiratory, pain relief, digestive health, and allergy-related needs under brands including Sensodyne, Polident, Parodontax, Biotene, Centrum, Emergen-C, Caltrate, Theraflu, Flonase, Voltaren, Panadol, Advil, TUMS, ENO, and Fenistil. Haleon was founded in 1715 and is headquartered in Weybridge, United Kingdom.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-HLN
|
$10.80
|
8.6% Upside
|
Fair
|
$11.65
|
17.1% Upside
|
Fair
|
Great
|
—
|
—
|
0.3077
|
2.5%
|
July 30, 2026
|
19.5x
|
2.0x
|
3.0x
|
43.848 B
|
53.774 B
|
20.9%
|
99.7%
|
19.3
|
36.7%
|
138.7%
|
